iwCAR-T 2020

The International Workshop on CAR-T 2020 took place October 29–30th and highlighted recent updates in CAR T-cell therapy across a variety of hematological oncology indications.

Some of the world’s leading clinical researchers shared their perspectives on how to place our evolving understanding in a clinical context and thereby optimize clinical care.

The full series of presentations can be viewed on-demand below.

Day 1 Day 2 CAR-T & Cellular Therapy Focus iwCAR-T.org

Day One

Day one of the meeting featured sessions on CAR-T in ALL, AML and CLL.

Session I: CAR-T in ALL
  • Novel CAR-T approaches for ALL: Rebecca Gardner
  • CAR-T in adult ALL; Claire Roddie
  • Allogeneic CAR-T in ALL: Bijal Shah
  • Remission & Persistence: Shannon Maude
Session I
Session II: CAR-T in AML
  • Overview: Saar Gill
  • CART vs BITE for AML: John DiPersio
  • NKG2D and anti-CD33 CART: David Sallman
Session II
Session 3: CAR-T in CLL
  • Update CLL CAR-T trial landscape/JCAR; Tanya Siddiqi
  • The role of CLL tumor cells in resistance to anti-CAR-T cell therapy: Joseph Melenhorst 
  • Long-term outcomes of anti-CD19 CAR-T in R/R CLL: David Porter
Session III

Day Two

Day two of the meeting featured sessions on CAR-T in lymphoma, myeloma and the evolution of cellular therapies.

Session 4: CAR-T in Lymphoma
  • CD19-CAR-T cells – trial updates: Jeremy Abramson
Session IV
Session 5: CAR-T in Myeloma
  • BCMA CART – ready for standard of care practice?: Nina Shah
  • CART trials in China: myeloma and CART landscape in China: Jianxiang Wang
  • BITes vs CARs: Herman Einselle
  • Beyond BCMA, other novel CART targets and combinations: Eric Smith
Session V
Session 6: Evolution of cellular therapies
  • Tmod CAR T cells Targeting Loss of Heterozygosity: William Go
  • Repeat CAR T infusions (ALL, NHL and CLL): Jordan Gauthier
  • Novel CAR platforms – allogeneic CART, CAR-NK: Michael Hudecek
Session VI

CAR-T channel

Our CAR-T Channel examines the latest updates across the field.

 

With content featuring expert interviews from major international congresses, this is one for your bookmarks!

 

To keep updated on all the latest in CAR-T, subscribe to our newsletter here.

 

VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals